SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back

National Association for Continuing Education
Sandra G. Adams, MD, MS
Professor, Division of Pulmonary Diseases and Critical Care Medicine
UT Health San Antonio
Staff Physician, The South Texas Veterans Health Care System
Founder, President
WipeDiseases Foundation
San Antonio, TX

Independant Peer Reviewer
Robert W. Morrow, MD
Clinical Associate Professor,
Department of Family and Social Medicine
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, NY

CME Reviewer
Victor B. Hatcher, PhD
Associate Dean CME
Albert Einstein College of Medicine
Bronx, NY

Medical Writer
Cedric Nazareth, MBBS

: Optimizing COPD Management in Primary Care
Activity/Course #:
: NCME361
: Free
Release/Start Date:
: Oct 31 2018
Expiration Date:
: Oct 30 2019
: Pulmonology
Target Audience:
: Primary Care Physicians, Nurse Practitioners, Physician Assistants
: Monograph
Estimated Time To Complete CME Activity:
: 1.0 Hour
: 1.0 AMA PRA Category I Credit(s)
1.0 AANP Contact hour(s) which includes 0.75 pharmacology hour(s)
Hardware/Software Requirements:
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the United States, claiming more than 120,000 lives in the United States each year. The disease has a major impact on functional abilities and quality of life (QoL) and costs the U.S. economy an estimated $49.9 billion per year in healthcare expenditures and indirect costs related to morbidity and mortality. Appropriate management of COPD can relieve symptoms, improve health status, decrease exacerbations and reduce hospitalizations.

This activity will focus on case-finding strategies to identify patients with unrecognized but clinically significant COPD, tailoring pharmacological strategies to meet the individualized needs of the patient, the importance of proper inhaler technique, and how to prevent and manage COPD exacerbations.

Learning Objective(s):

 After completing this program participants should be able to:

  1. Describe “case finding” strategies to identify patients with unrecognized, clinically significant chronic obstructive pulmonary disease (COPD)
  2. Tailor COPD pharmacotherapy according to current recommended therapeutic guidelines which incorporate unique patient needs and characteristics
  3. Discuss strategies to facilitate the appropriate use of inhaled therapies for COPD including proper inhaler technique
  4. Recognize appropriate strategies to prevent and manage COPD exacerbations and provide transitions of care post hospitalization

  How to obtain the CME Certificate

  1. Register for the course at
  2. View the content.
  3. Complete the post-test  until successful, and submit it  with the evaluation.
  4. A minimum passing score of 70% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate.
Sponsored and Certified By
Albert Einstein College of Medicine
Accreditation Designation Statement
Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Albert Einstein College of Medicine designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Creditô. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1.0 contact hour of continuing education (which includes 0.75 pharmacology hours).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure:
Conflict of Interest Disclosure Policy: In accordance with the ACCME Standards for Commercial Support, the
Albert Einstein College of Medicine requires that individuals in a position to control the content of an
educational activity disclose all relevant financial relationships with any commercial interest. Albert Einstein
College of Medicine resolves all conflicts of interest to ensure independence, objectivity, balance, and
scientific rigor in all its educational activities. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present. Albert
Einstein College of Medicine also requires that faculty participating in any CME activity disclose to the
audience when discussing any unlabeled or investigational use of any commercial product or device not yet
approved for use in the United States. Faculty disclosures are provided below.

Activity Planning Committee
Sandra G. Adams, MD has received Contracted Research support from AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi Sankyo, GlaxoSmithKline, Novartis Pharmaceuticals, and Sunovion Pharmaceuticals, Inc.

Robert W. Morrow, MD, has no financial relationships to disclose.

Cedric Nazareth, Medical Writer, has no relationships to disclose.

Harvey C. Parker, Ph.D., has no relationships to disclose.

Gregg Sherman, MD, has no relationships to disclose.

Deborah Paschal, CRNP, has no relationships to disclose.

Michelle Frisch, MPH, has no relationships to disclose.

Victor B. Hatcher, PhD, has disclosed no relevant finalcial relationships

Daniela Hiedra has no relationships to disclose.

Sandy Bihlmeyer, MEd, has no relationships to disclose.

Alan Goodstat, LCSW, has no relationships to disclose.

The staff of the Center of Continuing Education of Albert Einstein College of Medicine have no conflict of interest with commercial interests related directly or indirectly to this educational activity

The information presented in this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patientís medical condition.

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Albert Einstein College of Medicine, Montefiore Medical Center, the National Association for Continuing Education, or GlaxoSmithKline. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
This educational activity is supported by an educational grant from GlaxoSmithKline.